Gustaaf W. van Imhoff

Author

Also Known As

G W Van Imhoff, G W van Imhoff, G. W. Van Imhoff, G. W. van Imhoff, G.W. Van Imhoff, G.W. van Imhoff, G.W.Van Imhoff, GUSTAAF W. van IMHOFF, Gustaaf W Van Imhoff, Gustaaf W van Imhoff

127

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Radboud University Nijmegen Erasmus MC University Medical Center Utrecht

About

Gustaaf W. van Imhoff is an author at University Medical Center Groningen specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.3K
2	Health Sciences	9	9	328
3	Allergy	2	2	179
4	Public Health	1	1	88
5	Social Sciences	1	1	79

Gustaaf W. van Imhoff

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond, New England Journal of Medicine	2015	605
Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study Justin Pijpe, Gustaaf W. van Imhoff, Fred K. L. Spijkervet, Arthritis & Rheumatism	2005	491
Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma Leo F. Verdonck, Wim L.J. van Putten, Anton Hagenbeek, New England Journal of Medicine	1995	280
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study Gustaaf W. van Imhoff, Andrew McMillan, Matthew J. Matasar, Journal of Clinical Oncology	2017	231
Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma Gustaaf W. van Imhoff, Evert-Jan G. Boerma, Bronno van der Holt, Journal of Clinical Oncology	2006	173
CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff, Journal of Clinical Oncology	2003	168
Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups Kevin Y. Urayama, Ruth F. Jarrett, Henrik Hjalgrim, JNCI Journal of the National Cancer Institute	2012	167
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial Edo Vellenga, Wim L.J. van Putten, Mars B. van ’t Veer, Blood	2007	165
Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma Eugenia Haralambieva, Evert-Jan G. Boerma, Gustaaf W. van Imhoff, The American Journal of Surgical Pathology ImmunologyPathologyImmunophenotypingImmunotherapyHematological Malignancy	2005	149
Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive Anneke Bosga-Bouwer, Gustaaf W. van Imhoff, Ronald Boonstra, Blood	2003	142

Page 1